These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2184731)

  • 21. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the novel T-selective calcium channel antagonist mibefradil on kidney function in comparison with amlodipine.
    Greven J
    Arzneimittelforschung; 1998 Aug; 48(8):806-10. PubMed ID: 9748707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addition of isradipine (Lomir) results in a better renal function after kidney transplantation: a double-blind, randomized, placebo-controlled, multi-center study.
    van Riemsdijk IC; Mulder PG; de Fijter JW; Bruijn JA; van Hooff JP; Hoitsma AJ; Tegzess AM; Weimar W
    Transplantation; 2000 Jul; 70(1):122-6. PubMed ID: 10919587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PGl2 analogue mitigates the progression rate of renal dysfunction improving renal blood flow without glomerular hyperfiltration in patients with chronic renal insufficiency.
    Fujita T; Fuke Y; Satomura A; Hidaka M; Ohsawa I; Endo M; Komatsu K; Ohi H
    Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):223-7. PubMed ID: 11728176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endotoxin-induced acute renal failure in the rat: effects of urodilatin and diltiazem on renal function.
    Schramm L; Heidbreder E; Lukes M; Weierich T; Lopau K; Zimmermann J; Wanner C
    Clin Nephrol; 1996 Aug; 46(2):117-24. PubMed ID: 8869789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the calcium antagonist manidipine on renal hemodynamics and function in dogs: comparison with nifedipine.
    He H; Tamaki T; Aki Y; Kiyomoto H; Iwao H; Miyatake A; Abe Y
    Blood Press Suppl; 1992; 3():68-74. PubMed ID: 1343294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diltiazem modulates cyclosporin A induced renal hemodynamic effects but not its effect on plasma endothelin-1.
    Asberg A; Christensen H; Hartmann A; Berg KJ
    Clin Transplant; 1998 Oct; 12(5):363-70. PubMed ID: 9787942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do calcium channel blockers protect against renal ischemia?
    Puschett JB
    Am J Nephrol; 1987; 7 Suppl 1():49-56. PubMed ID: 3327381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal effects of calcium entry blockers.
    Ruilope LM; Alcazar JM
    Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():979-82. PubMed ID: 2076410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal protection with the calcium antagonists.
    Neumayer HH; Kunzendorf U
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S11-8. PubMed ID: 1723449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive therapy and mobilization of renal functional reserve.
    Burnier M; Biollaz J; Steinhauslin F; Brouard R; Waeber B; Brunner HR
    Clin Invest Med; 1991 Dec; 14(6):581-9. PubMed ID: 1686579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of calcium channel blockers on cyclosporine and its metabolites in renal transplant recipients.
    Tortorice KL; Heim-Duthoy KL; Awni WM; Rao KV; Kasiske BL
    Ther Drug Monit; 1990 Jul; 12(4):321-8. PubMed ID: 2396304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal effects of felodipine--a review.
    Elmfeldt D; Nordlander M; Edgar B
    Kidney Int Suppl; 1992 May; 36():S54-60. PubMed ID: 1614069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium antagonists and the kidney.
    Pearce CJ; Wallin JD
    New Horiz; 1996 Feb; 4(1):123-8. PubMed ID: 8689267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium antagonists and renal hemodynamics: implications for renal protection.
    Epstein M
    Clin Invest Med; 1991 Dec; 14(6):590-5. PubMed ID: 1794210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium channel blockade and renal function.
    Odar-Cederlöf I
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():81-9. PubMed ID: 3521200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of calcium-channel blockers on renal function in renal-graft recipients treated with cyclosporine.
    Hauser AC; Derfler K; Stockenhuber F; Wamser P; Marosi L; Balcke P
    N Engl J Med; 1991 May; 324(21):1517. PubMed ID: 2023618
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.